Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency
NCT04594668
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
46
Enrollment
OTHER
Sponsor class
Conditions
ARDS, Human
COVID
Interventions
DRUG:
Senicapoc
Sponsor
University of Aarhus
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]